This effect of TGR5 activation is mediated not only through a reduction in blood glucose, but also by protecting EC function by increasing eNOS expression, promoting GLP-1 secretion, reducing insulin resistance, and reducing oxidative stress and inflammation (Figure 2). This evidence concerns the gene GPBAR1 and Insulin resistance.